3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Sarcoma
17
Glioblastoma
10
Brain Neoplasms
10
Gliosarcoma
9
Rhabdomyosarcoma
7
Osteosarcoma
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Sarcoma, Ewing
5
Recurrence
5
Leukemia, Myeloid, Acute
5
Dendritic Cell Sarcoma, Interdigitating
5
Burkitt Lymphoma
5
Astrocytoma
5
Oligodendroglioma
4
Myeloproliferative Disorders
4
Myelodysplastic Syndromes
4
Multiple Myeloma
4
Lymphoma, Non-Hodgkin
4
Lymphoma, Mantle-Cell
4
Lymphoma, Follicular
4
Lymphoma, B-Cell, Marginal Zone
4
Lymphoma
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Leukemia
4
Hodgkin Disease
4
Glioma
4
Rhabdoid Tumor
3
Primary Myelofibrosis
3
Neurofibrosarcoma
3
Neuroblastoma
3
Interventions
X-Rays
6
Phantoms, Imaging
6
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Cyclophosphamide
5
Nuclear Medicine Department, Hospital
4
Melphalan
4
Granulocyte Colony-Stimulating Factor
4
Thiotepa
3
Mesna
3
Filgrastim
3
Etoposide
3
Busulfan
3
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
fludarabine
2
ensartinib
2
Vemurafenib
2
Temozolomide
2
Peripheral Blood Stem Cell Transplantation
2
Nivolumab
2
LY3023414
2
Ifosfamide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hepatoblastoma
×
Sirolimus
×
Sarcoma
×
Clear all
NCT01331135
2020-05-29
Aflac ST0901
Emory University
Phase 1
Completed
18 enrolled